Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for Small Business Innovation Research (SBIR) Phase IIB Bridge Awards aimed at accelerating the development of cancer-relevant technologies toward commercialization. This funding opportunity is designed for small business concerns (SBCs) that have previously received SBIR or STTR Phase II awards from any Federal agency and are seeking additional funding to transition their projects to the commercialization stage. The initiative emphasizes the importance of fostering partnerships between awardees and third-party investors to support the capital-intensive steps necessary for bringing new products and services to market. While applications are not currently being solicited, the NOFO is expected to be published in Summer 2025, with an anticipated application due date in Fall 2025. For further inquiries, interested parties can contact Jonathan Franca-Koh, Ph.D., M.B.A. at 240-618-0984 or via email at francakohjc@mail.nih.gov.